Exercise-Induced Muscle Factor Promotes Memory

Running releases an enzyme that is associated with memory function in mice and humans.  

Jun 23, 2016
Ruth Williams

New brain cells (green) are induced by exerciseHENRIETTE VAN PRAAG AND LINDA KITABAYASHIWorking out is good for the brain. Now, a team of scientists from the U.S. and Germany has a clearer idea why. A protein called cathepsin B, produced and secreted by muscle during exercise, is required for exercise-induced memory improvement and brain cell production in mice, the scientists reported in Cell Metabolism today (June 23). They also showed that levels of cathepsin B are positively correlated with fitness and memory in humans.

“This is a super exciting area. Exercise has so many health benefits, yet we know so little about many of these effects at a molecular level,” said biologist David James of the University of Sydney who did not participate in the work.

“This paper provides a convincing mechanism that involves running-induced increases in a particular protein—cathepsin B—that appears to promote neurogenesis by enhancing expression of a growth factor—BDNF—in the brain,” added neuroscientist Paul Frankland of the University of Toronto who also was not involved in the study. “This is a long chain of events, from exercise to muscle to brain to cognition,” he said, “but the authors do a great job at demonstrating each of the links.”

Running has been shown in animals to have a variety of effects on the brain, including enhanced memory function and increased production of new brain cells (neurogenesis). In humans, a correlation between exercise and memory function has also been observed. But how muscle activity might be mechanistically linked to memory has been somewhat of a mystery.

To hunt for mucle-produced factors called myokines that might modulate brain function, Henriette van Praag of the National Institute on Aging and colleagues treated rat muscle cells in culture with the drug AICAR—“an exercise mimetic,” explained van Praag, meaning it boosts the cells’ metabolic activities. Among the proteins upregulated in the treated cells was a secreted factor, small enough to traverse the blood-brain barrier, that had previously been shown to be upregulated in muscle during exercise: cathepsin B.

In mice that exercised for two to four weeks, plasma levels of cathepsin B were significantly increased, van Praag’s team found. And the animals showed improved memory as well as increased neurogenesis in their hippocampi—a brain region involved in learning and memory. Mice that were genetically engineered to lack cathepsin B, on the other hand, did not show these exercise-related effects.

The team also showed that cathepsin B treatment of murine adult hippocampal progenitor cells in culture induced the expression of two key nerve growth factors—brain-derived neurotrophic factor (BDNF) and doublecortin—which may explain how the myokine induces neurogenesis.

In rhesus monkeys and humans, four months of treadmill training increased blood levels of cathepsin B, the team showed, and this increase was correlated with improved memory recall in the human study participants.

Intriguingly, while some earlier studies have reported cathepsin B to have neuroprotective effects, a number of others have suggested that cathepsin B is involved in neuronal cell death during brain injury and the onset of Alzheimer’s disease. Others have reported high levels of cathepsin B in various cancers.

With that in mind, “the observation that [cathepsin B] might encode benefits of exercise in the brain is almost counter-intuitive,” said James.

If the link between cathepsin B and improved memory can be confirmed in humans, however, then “pharmacological targeting of cathespin b might be used to enhance cognition,” suggested Frankland.

Exercise itself might also provide such cognitive benefit, of course, but “a lot of people who are at risk of Alzheimer’s disease are not very mobile, or they have cardiovascular problems that prevent them from exercising,” explained study coauthor Emrah Düzel of the German Center for Neurodegenerative Diseases and of University Madeburg. “So identifying peripheral factors that you could substitute without having the need to actually exercise would be important.”

H.Y. Moon et al., “Running-induced systemic cathepsin B secretion is associated with memory function,” Cell Metabolism, doi:10.1016/j.cmet.2016.05.025, 2016.


January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb


Sponsored Product Updates

Horizon Discovery extends CRISPR Screening Service to primary human T cells
Horizon Discovery extends CRISPR Screening Service to primary human T cells
Horizon Discovery Group plc (LSE: HZD) (“Horizon” or “the Company”), a global leader in gene editing and gene modulation technologies, today announced the extension of its CRISPR Screening Service to includeex vivoT lymphocytes. The service extension meets the requirements of immunology-based research in drug discovery,enabling new gene targets to be identified in biologically and potentially therapeutically relevant settings.
pIC50: The Advantages of Thinking Logarithmically
pIC50: The Advantages of Thinking Logarithmically
Watch this webinar from Collaborative Drug Discovery to learn about how using pIC50 helps you get a better sense of the relative potencies, calculate the correct mean of multiple values, and select better sampling doses.
WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
INTEGRA Biosciences is offering labs the chance to win a VIAFLO 96/384 pipette. Designed to simplify plate replication, plate reformatting or reservoir-to-plate transfers, the VIAFLO 96/384 allows labs without the space or budget for an expensive pipetting robot to increase the speed and throughput of routine tasks.
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.